Outpatient versus inpatient intravaginal misoprostol for the treatment of first trimester incomplete miscarriage: a randomised controlled trial

Archives of Gynecology and Obstetrics

Volumn 291, Issue 1, 2015, Pages 105-113

  Ng, Beng Kwang ^a   Annamalai, Ramanathan ^a   Lim, Pei Shan ^a   Suraya, Sulaiman Aqmar ^a   Azurah, Abdul Ghani Nur ^a   Abdul Jamil, Mohd Yassin Muhammad ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

First trimester miscarriage; Inpatient; Intra vaginal misoprostol; Outpatient; Randomised controlled trial

Indexed keywords

MISOPROSTOL; ABORTIVE AGENT;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIARRHEA; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; ENDOMETRIAL THICKNESS; FEMALE; FEVER; FIRST TRIMESTER PREGNANCY; HOSPITAL PATIENT; HUMAN; MALAYSIA; NAUSEA; OUTCOME ASSESSMENT; OUTPATIENT CARE; PAIN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION; TERTIARY CARE CENTER; ABORTION, INCOMPLETE; AMBULATORY CARE; COMPARATIVE STUDY; INDUCED ABORTION; INTRAVAGINAL DRUG ADMINISTRATION; OUTPATIENT; PREGNANCY; PROCEDURES; UTERINE CERVIX;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INCOMPLETE; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADULT; AMBULATORY CARE; CERVIX UTERI; FEMALE; HUMANS; INPATIENTS; MISOPROSTOL; OUTPATIENTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES;

EID: 84926652802     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-014-3388-0     Document Type: Article

References (36)

1. Laferia JJ (2006) Spontaneous abortion. Clin Obstet Gynecol 13:105-114
2. Wang X, Chen C, Wang L et al (2003) Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study. Fertil Steril 79(3):577-584
3. Petrozza JC. Early pregnancy loss. E medicine, WebMD. (Retrieved 20th July 2007)
4. Hooker AB, Lemmers M, Thurkow AL et al (2014) Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome. Hum Reprod Update 20(2):262-278
5. Al-Ma'ani W, Solomaver EF, Hammadeh M (2014) Expectant versus surgical management of first-trimester miscarriage: a randomised controlled study. Arch Gynecol Obstet 289(5):1011-1015
6. Patua B, Dasqupta M, Bhattacharyya SK et al (2013) An approach to evaluate the efficacy of vaginal misoprostol administered for a rapid management of first trimester spontaneous onset incomplete abortion, in comparison to surgical curettage. Arch Gynecol Obstet 288(6):1243-1248
7. Demetroulis C, Saridogan E, Kunde D et al (2001) A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure. Human Rep 16(2):365-369
8. Chung TK, Lee DT, Cheung LP et al (1999) Spontaneous abortion: a randomized, controlled trial comparing surgical evacuation with conservative management using misoprostol. Fertil Steril 71:1054-1059
9. Harris LH, Dalton VK, Johnson TRB (2007) Surgical management of early pregnancy failure: history, politics, and safe, cost effective care. Am J Obstetric Gynecol 196:445-446
10. Geyman JP, Oliver LM, Sullivan SD (1999) Expectant, medical or surgical treatment of spontaneous abortion in first trimester of pregnancy. A pooled quantitative literature evaluation. J Am Board Fam Pract 12(1):55-64
11. Gemzell KD, Marions L, Rodriguez A et al (1999) Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol 93:275-280
12. Rabe T, Basse H, Thuro H et al (1987) Action of PGE1 methyl analogue misoprostol on pregnant human uterus in the first trimester. Geburtshilfe Frauenheilkd 47(5):324-331
13. Blanchard K, Clark S, Winikoff B et al (2002) Misoprostol for women's health: review. Obstet Gynecol 99:316-332
14. Kulier R, Kapp N, Gulmezoglu AM et al (2011) Medical methods for first trimester abortion. Cochrane Database of Syst Rev 11:CD002855
15. Zieman M, Fong SK, Benowitz NL et al (1997) Absorption kinetics of misoprostol with oral and vaginal administration. Obstet Gynecol 90:88-92
16. Tang OS, Schweer H, Seyberth HW et al (2002) Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 17:332-336
17. Khan RU, El-Refaey H (2003) Pharmacokinetics and adverseeffect profile of rectally administered misoprostol in third stage of labor. Obstet Gynecol 101:968-974
18. Kong GW, Lok IH, Yiu AK et al (2013) Clinical and psychological impact after surgical, medical or expectant management of first-trimester miscarriage-a randomised controlled trial. Aust N Z J Obstet Gynaecol 53(2):170-177
19. Rausch M, Lorch S, Chung K et al (2012) A cost-effectiveness analysis of surgical versus medical management of early pregnancy loss. Fertil Steril 97(2):355-360
20. Schaff EA, Staalius LS, Eisinger SH et al (1997) Vaginal misoprostol administered at home after mifepristone for abortion. J Fam Pract 44(4):353-360
21. Fiala C, Winikoff B, Helstrom L et al (2004) Acceptability of home-use of misoprostol in medical abortion. Contraception 70:387-392
22. Guengant JP, Bangou J, Elul B et al (1999) Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe. Contraception 60:167-172
23. Elul B, Hajri S, Ngoc NN et al (2001) Can women in less developed countries use a simplified medical abortion regime. Lancet 357:1402-1405
24. Ngo TD, Park MH, Shakur H et al (2011) Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: a systematic review. Bull World Health Organ 89:360-370
25. Pang MW, Lee TS, Chung TKH (2001) Incomplete miscarriage: a randomized controlled trial comparing oral with vaginal misoprostol for medical evacuation. Hum Reprod 16(11):2283-2287
26. Coughlin LB, Roberts D, Haddad NG et al (2004) Medical management of first trimester incomplete miscarriage using misoprostol. J Obstet Gynaecol 24(1):67-68
27. (2011) The use of off-label drugs for obstetrics and gynecology in MOH facilities. Bahagian Perkhidmatan Farmasi, Ministry of Health Malaysia
28. Reif P, Tappauf C, Panzitt T et al (2013) Efficacy of misoprostol in relation to uterine position in the treatment of early pregnancy failure. Int J Gynaecol Obstet 121(2):137-140
29. Ngoc NT, Shochet T, Blum J et al (2013) Results from a study using misoprostol for management of incomplete abortion in Vietnamese hospitals: implications for task shifting. BMC Pregnancy Childbirth 13:118
30. Peterson SG, Perkins A, Gibbons K et al (2013) Can we use a lower intravaginal dose of misoprostol in the medical management of miscarriage? A randomised controlled study. Aust N Z J Obstet Gynaecol 53(1):64-73
31. Hedley A, Trussell J, Turner AN et al (2004) Differences in efficacy, differences in providers: results from a hazard analysis of medical abortion. Contraception 69:157-163
32. Carbonell JLL, Varela L, Velazco A et al (1999) Early abortion with 800 mcg of misoprostol by the vaginal route. Contraception 59:219-225
33. Goldberg AB, Greenberg MB, Darney PD (2001) Misoprostol and pregnancy. N Engl J Med 344:38-47
34. Tang OS, Gemzell-Danielsson K, Ho PC (2007) Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet 99:160-167
35. Dagousset I, Fourrier E, Aubény E et al (2004) Use of misoprostol for medical abortion: a trial of the acceptability for home use. Gynecol Obstet Fertil 32:28-33
36. Stein K, Winikoff B, Kallianes V (1998) Abortion: expanding access and improving quality. Robert H. Ebert program on critical issues in reproductive health working paper. Population Council, New York